Some patients stay on GLP-1 medications long term while others taper off after reaching their weight goal
Funcin renal y heptica : Segn la etiqueta de la FDA, tirzepatide se elimina principalmente mediante degradacin proteoltica (descomposicin de protenas) y no requiere ajuste de dosis en pacientes con insuficiencia renal, incluida la enfermedad renal en etapa terminal, ni en pacientes con insuficiencia heptica
Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J, et al
SURMOUNT-1 showed greater weight loss with tirzepatide (20.9%) vs
Regular monitoring and open communication with your medical team will help mitigate these risks
PlexusDx prescribers use these insights to make confident, individualized recommendations about your tirzepatide regimen